Skip to contentM
Medifast Inc
M
MEDMedifast Inc Q2 2020 · 10-Q
Revenue$220.00M$220.00M+17.6% vs Q2 2019 Net Income$21.94M$21.94M+2.6% vs Q2 2019 EPS Diluted$1.86$1.86+6.3% vs Q2 2019 Gross Profit$159,300,000+13.2% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Medifast Inc · CIK 910329 · Engraved from SEC EDGAR
Operating Cash Flowderived$57,518,000+297.3% Free Cash Flowderived$57,229,000+378.9% Margins · derivedGross margin72.4%−2.8 pt vs Q2 2019
Operating margin12.8%−1.8 pt vs Q2 2019
Net margin10.0%−1.5 pt vs Q2 2019
ended Jun 30, 2020 · filed Aug 6, 2020 · 37 d after period end